Proteomics

Bertis, a South Korean proteomics-based precision medicine technology company, has established a US-based wholly-owned entity to expand its global presence. The subsidiary, called Bertis Bioscience, aims to establish a San Diego-based CLIA-certified lab facility in early Q4, 2022. It will offer proteomics-based screening and diagnostic tests, as well as an analysis platform to integrate multi-omics […]

Alamar Biosciences, a proteomics platform, and Abcam, innovators in life sciences research tools, have partnered to further their understanding of the human proteome.  Proteomics  The field of proteomic analysis is in the spotlight. Its advance not only enhances the understanding of fundamental biology, but also sheds light on the status of human health and disease. […]

Many small molecule inhibitors have been approved as cancer therapeutics, but they can confer mutation-based drug resistance and many potential cancer targets remain ‘undruggable’.  One emerging cancer therapeutic strategy that shows promise for drug development is the use of targeted protein degradation (TPD). This approach has many advantages, including the ability to aim at previously inaccessible […]

This On Demand webinar by Olink features Bill Hunt, Director of Product Management at Fluidigm, and Dr Jenny Rubin, Development Engineer at Olink Proteomics. The webinar examines the new Olink Signature Q100, a benchtop system for protein biomarker analysis.  Hunt discusses “Signature Q100 System – Evolution of workhorse for protein expression”, while Rubin will look at the “Side by side comparison of Olink to […]

Bruker has launched new products, as outlined June 1-3, 2021 at the eXceed Symposia 2021. The products include timsTOF trueSCP and timsTOF Pro 2. Mass spectrometric proteomics has become a staple of modern research in understanding biological function and disease mechanisms. Healthy or diseased tissues that seem homogenous are composed of cells with a variety […]

Olink has created a whitepaper which pulls together three recently published research studies highlighting the importance of linking genetic and protein expression data in the context of disease phenotypes in order to identify new, robust drug targets. According to Olink, while many drugs are developed based on genomic findings, it’s common for these drugs to […]

Lu Rahman looks at the rise of proteomics, its growing role in the quest for new treatments and some of the work being carried out in this field. Due to the introduction of technology-enabled proteomics products, the global proteomics market is expected to reach $24.8 billion by 2024, says Grand View Research. It notes that these […]